Technical Toolboxes Announces Strategic Growth Investment From BVP Forge To Accelerate Innovation in Energy Infrastructure Software
UF startup Technical Toolboxes, a leading provider of advanced engineering and maintenance software for energy infrastructure, announced a strategic growth investment from BVP Forge.
SandboxAQ and iOncologi Partner To Accelerate Brain Cancer Treatment With AI-Driven Drug Discovery for Glioblastoma
SandboxAQ and UF startup iOncologi have announced a strategic collaboration to co-develop, validate, and commercialize a novel high-fidelity mRNA vaccine targeting glioblastoma—the most common and aggressive malignant brain tumor in adults.
Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy To Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Solid Biosciences, which acquired UF startup AavantiBio, announced FDA and Health Canada approval to begin clinical trials of SGT-501, a gene therapy targeting CPVT, a severe heart rhythm disorder caused by RYR2 mutations.
Atsena Therapeutics Announces Alignment With FDA on Regulatory Pathway to Approval for ATSN-201 in X-Linked Retinoschisis (XLRS)
UF startup Atsena Therapeutics received FDA approval to expand its Phase 1/2 LIGHTHOUSE study of ATSN-201 into a pivotal Phase 1/2/3 trial to support a BLA submission for treating X-linked retinoschisis (XLRS).
TuHURA Biosciences Initiates Its Phase 3 Accelerated Approval Trial of IFx-2.0 as an Adjunctive Therapy to Keytruda® (Pembrolizumab) in First Line Treatment for Advanced or Metastatic Merkel Cell Carcinoma
TuHURA Biosciences, formed by CohBar and Morphogenesis, a UF startup, has announced the initiation of its Phase 3 accelerated approval trial of IFx-2.0, TuHURA's lead innate immune agonist, in patients with advanced or metastatic Merkel cell carcinoma (MCC).
LightPath Debuts First Industrial-Grade Cooled Optical Gas Imaging Camera
UF startup LightPath Technologies announced that its subsidiary, G5 Infrared, has launched its first industrial-grade MWIR optical gas imaging camera, following a successful test at a certified facility.
Myosin Therapeutics Receives FDA Clearance To Initiate First-in-Human Trial of MT-125 in Glioblastoma
UF startup Myosin Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) application for MT-125.
Florida Venture Forum Announces Startups Selected to Present at 2025 Florida Early Stage Venture Conference
Oboro Labs, a UF startup, is among the companies selected to pitch at the 2025 Florida Early Stage Venture Conference, showcasing the innovative technologies emerging from UF’s entrepreneurial ecosystem.
Tech Tuesday: University of Florida Startup Is Changing How Students Connect With Classmates
In this week’s Tech Tuesday, UF Innovate host Bethany Gaffey introduces CourseLynx, a UF startup transforming how students connect on campus and in class.
Atsena Therapeutics Announces Positive Clinical Data From Part A of Phase I/II Trial Evaluating ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis (XLRS)
UF startup Atsena Therapeutics announced positive clinical data results from Part A of the LIGHTHOUSE study, a Phase I/II clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).